Literature DB >> 15781400

Synthesis and human NKT cell stimulating properties of 3-O-sulfo-alpha/beta-galactosylceramides.

Guo-Wen Xing1, Douglass Wu, Michael A Poles, Amir Horowitz, Moriya Tsuji, David D Ho, Chi-Huey Wong.   

Abstract

Two novel hybrid molecules 3-O-sulfo-alpha/beta-galactosylceramide 3 and 4, which are derived from an immunostimulatory agent alpha-GalCer 1 and self-glycolipid ligand sulfatide 2, were designed and synthesized. Compound 3 was shown to efficiently stimulate human NKT cells to secret IL-4 and IFN-gamma, with activities similar to 1, suggesting that modification of the 3''-OH position of the galactose moiety with sulfate has no significant effect on NKT cell stimulation. As a comparison, the beta-isomer 4 has no affinity to NKT cells, which demonstrates that the alpha-glycosidic bond of galactosylceramide is crucial to the NKT cells activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781400     DOI: 10.1016/j.bmc.2005.02.018

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  15 in total

1.  Divergent synthetic approach to 6''-modified α-GalCer analogues.

Authors:  Nora Pauwels; Sandrine Aspeslagh; Gerd Vanhoenacker; Koen Sandra; Esther D Yu; Dirk M Zajonc; Dirk Elewaut; Bruno Linclau; Serge Van Calenbergh
Journal:  Org Biomol Chem       Date:  2011-11-01       Impact factor: 3.876

Review 2.  Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant.

Authors:  Neal N Padte; Xiangming Li; Moriya Tsuji; Sandhya Vasan
Journal:  Clin Immunol       Date:  2010-12-24       Impact factor: 3.969

3.  The total synthesis of immunostimulant α-galactosylceramides from naturally configured α-galactoside raffinose.

Authors:  Zhenxing Zhang; Wei Zhao; Bin Wang; Chengfeng Xia; Wenpeng Zhang; Peng George Wang
Journal:  Org Lett       Date:  2011-08-04       Impact factor: 6.005

4.  Synthesis of all stereoisomers of KRN7000, the CD1d-binding NKT cell ligand.

Authors:  Jeong-Ju Park; Ji Hyung Lee; Subhash C Ghosh; Gabriel Bricard; Manjunatha M Venkataswamy; Steven A Porcelli; Sung-Kee Chung
Journal:  Bioorg Med Chem Lett       Date:  2008-06-14       Impact factor: 2.823

5.  4"-O-Alkylated α-Galactosylceramide Analogues as iNKT-Cell Antigens: Synthetic, Biological, and Structural Studies.

Authors:  Jonas Janssens; Aruna Bitra; Jing Wang; Tine Decruy; Koen Venken; Johan van der Eycken; Dirk Elewaut; Dirk M Zajonc; Serge van Calenbergh
Journal:  ChemMedChem       Date:  2018-12-17       Impact factor: 3.466

Review 6.  Raising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells.

Authors:  James E East; Andrew J Kennedy; Tonya J Webb
Journal:  Med Res Rev       Date:  2012-12-13       Impact factor: 12.944

Review 7.  Glycolipids as immunostimulating agents.

Authors:  Douglass Wu; Masakazu Fujio; Chi-Huey Wong
Journal:  Bioorg Med Chem       Date:  2007-10-13       Impact factor: 3.641

Review 8.  Presentation of lipid antigens by CD1 glycoproteins.

Authors:  André Schiefner; Ian A Wilson
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids.

Authors:  Ya-Jen Chang; Jing-Rong Huang; Yi-Chien Tsai; Jung-Tung Hung; Douglass Wu; Masakazu Fujio; Chi-Huey Wong; Alice L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-12       Impact factor: 11.205

10.  Syntheses and biological activities of KRN7000 analogues having aromatic residues in the acyl and backbone chains with varying stereochemistry.

Authors:  Jeong-Ju Park; Ji Hyung Lee; Kyung-Chang Seo; Gabriel Bricard; Manjunatha M Venkataswamy; Steven A Porcelli; Sung-Kee Chung
Journal:  Bioorg Med Chem Lett       Date:  2010-01-04       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.